Summit on Cancer Health Disparities (SCHD24)
This annual oncology conference, The Summit on Cancer Health Disparities (SCHD24), is one of the largest gatherings of cancer care professionals interested in cancer health disparities with a focus on achieving health equity. This year SCHD 2024 will feature lectures, panel discussions, and debates among leaders across the spectrum of cancer care delivery. This conference will bring together oncology professionals, cancer disparity researchers, and other stakeholders to discuss factors leading to cancer health disparities. A focus of the conference is to explore how these factors can be mitigated to optimize the outcomes of cancer patients. A distinctive feature of this conference is case-based discussions that will describe a problem, how it was solved, and the lessons learned.
SCHD 2024 is an accredited continuing education activity (CME activity) that will foster collaborative interdisciplinary interactions and partnerships to stimulate the development of new research and clinical practices that reduce cancer health disparities and improve outcomes of the diverse patient population.
Target Audience
- Oncologists
- Nurse Practitioners
- Physician Assistants
- Nurses
- Pharmacists
- Fellows/Residents
- Researchers
- Others interested in cancer disparities
Organizing Committee
Program Director:
Dr. Binay Shah - Binaytara Foundation
Conference Co-Chairs:
Dr. Ana María López - Sidney Kimmel Cancer Center, Thomas Jefferson University
Dr. David Aboulafia - Virginia Mason Medical Center
Dr. Hannah Linden - University of Washington and Fred Hutchinson Cancer Center
Organizing Committee:
Dr. Martha Pritchett Mims - Baylor College of Medicine
Dr. Jorge Cortes - Georgia Cancer Center at Augusta University
Dr. Kamran Mirza - University of Michigan
Dr. Ishwaria Subbiah - Sarah Cannon Research Institute
Dr. Siddhartha Yadav - Mayo Clinic
Dr. Dan Milner - Union for International Cancer Control
Abstract Committee Co-Chairs:
Dr. Martha Pritchett Mims - Baylor College of Medicine
Dr. Darya Kizub - MD Anderson Cancer Center
Dr. Siddhartha Yadav - Mayo Clinic
Abstract Committee:
Dr. Ronan Hsieh - University of Washington and Fred Hutchinson Cancer Center
Dr. Srinivas Tantravahi - University of Utah Huntsman Cancer Institute
Dr. Manisha Bhattacharya - University of Pittsburgh Medical Center
Dr. Kamran Mirza - University of Michigan
Dr. Gregory Vidal - West Cancer Center
Dr. Ursa Brown-Glaberman - University of New Mexico Comprehensive Cancer Center
Dr. Fengting Yan - Swedish Cancer Institute
Dr. Dipesh Uprety - Karmanos Cancer Institute
Media and Publications Committee Co-Chairs:
Dr. Ishwaria Subbiah - Sarah Cannon Research Institute
Dr. Kamran Mirza - University of Michigan
Dr. Umang Swami - University of Utah Huntsman Cancer Institute
Sponsorship Committee Chair:
Dr. Fengting Yan - Swedish Cancer Institute
HOTEL RESERVATION
Attendees and supporters of this meeting can book their hotel room at the Grand Hyatt Seattle at the discounted rate of $209/night + applicable taxes and fees. This rate is based on single occupancy and is valid three days before/after the meeting. The cut-off date is 04 April 2024.
Click here to book your hotel room a the discounted rate.
Abstract Submission
Submit abstracts to present at the 2024 Summit on Cancer Health Disparities
Learning Objectives
Upon successful completion of this educational activity, participants will be able to:
- Identify drivers of cancer health disparities and review their impact on patients along the cancer continuum.
- Review barriers to using multidisciplinary cancer care and discuss evidence-based strategies to navigate these barriers to incorporate the new standards of care in managing patients with cancer.
- Discuss newer technologies and their impact on cancer health disparities.
- Review the effectiveness of various interventional approaches and incorporate evidence-based strategies to minimize cancer health disparities in specific populations.
- Describe challenges and develop novel approaches, including technology utilization, to improve underrepresented communities' participation in clinical trials.
- Discuss the role of government policies and health care legislation in cancer health disparities and policy changes needed to improve access to cancer care.
GLOBAL ONCOLOGY PROJECT
Click this link to learn more about our ongoing project building a 200-bed cancer hospital in Nepal: https://binayfoundation.org/cancer-hospital/
DAY 1 - APRIL 26, 2024
All times are listed in Pacific Time (PT)
07:00 AM – 08:00 AM: Registration, Breakfast, & Exhibits
08:00 AM – 08:15 AM Welcome
08:15 AM – 09:30 AM Session 1: Understanding Disparities
Session Chairs: David Aboulafia, MD and Gita Suneja, MD, MS
08:15 AM – 08:20 AM Introduction by Session Chairs
08:20 AM – 08:40 AM Unpacking Disparities to Inform Action - Michele Andrasik, PhD
08:40 AM – 09:00 AM Best Practices in Supporting LGBTQ+ Communities - Nakita Venus and Elle Brooks, MPH
09:00 AM – 09:30 AM Panel Discussion - Alan Brownell; Derrick Mapp
09:30 AM – 10:00 AM Break & Exhibits
10:00 AM – 11:30 AM Session 2: Disparities: Access To Diagnostics and Care
Session Chairs: Mark Pegram, MD and Kamran M. Mirza, MD, PhD
10:00 AM – 10:15 AM Pathology - Kamran M. Mirza, MD, PhD
10:15 AM – 10:30 AM Precision Oncology - Siddhartha Devarakonda, MD
10:30 AM – 10:45 AM GU Cancer - Ulka Vaishampayan, MD
10:45 AM – 11:00 AM Hematologic Malignancies - Irum Khan, MD
11:00 AM – 11:15 AM Lung Cancer - Nicholas P. Giustini, MD
11:15 AM – 11:30 AM Panel Discussion
11:30 AM – 12:15 PM Session 3: Caring for the Carers: Diversity, Inclusion, and Professional Well-Being of the Global Community of Cancer Care Professionals
Session Chair: Ishwaria Subbiah, MD, MS, FASCO
11:30 AM – 11:45 AM On Well-Being: Background and Rationale - Ana María López, MD, MPH, MACP
11:45 AM – 11:55 AM On Well-Being Transitions: Training and Trainees - Carrie Fisher, DO
11:55 AM – 12:05 PM An Experiential Session with 'the Best Medicine' - Carrie A. Horwitch, MD, MPH, MACP
12:05 PM – 12:15 PM Panel Discussion
12:15 PM – 01:15 PM Lunch & Exhibits
01:15 PM – 2:30 PM Session 4: Integration of Technology into Cancer Care
Session Chair: Manish Kohli, MD
01:15 PM – 01:35 PM Artificial Intelligence to Facilitate Cancer Care - Joseph Finkelstein, MD, PhD, FAMIA, FACMI
01:35 PM – 01:50 PM Digital Innovations in Cancer Care - Ana María López, MD, MPH, MACP
01:50 PM – 02:05 PM Using Deep Learning and Patient-Reported Data to Predict Symptom Deterioration during a Chemotherapy Course - Aref Smiley, PhD
02:05 PM – 02:30 PM Panel Discussion
02:30 PM – 02:45 PM Break & Exhibits
02:45 PM – 04:15 PM Session 5: Achieving Quality Through Value-Based Models for Cancer Care: Practical Solutions
Session Chair: Ana María López, MD, MPH, MACP
02:45 PM – 03:05 PM ASCO Certified Patient-Centered Cancer Care Standards - Stephen S. Grubbs, MD, FASCO
03:05 PM – 03:20 PM Value for Whom? How to Make Value for Patients - Barbara L. McAneny, MD
03:20 PM – 03:35 PM Patient Perspectives on Cancer Care Delivery & Survivorship - Shelley Fuld Nasso, MPP
03:35 PM – 03:50 PM Beyond the Measures: Advancing Quality in Healthcare - Michael Barr, MD, MBA, MACP, FRCP
03:50 PM – 04:15 PM Panel Discussion
04:15 PM – 05:30 PM Reception & Networking
**By invitation only**
06:00 PM – 09:00 PM Career Connections Event and Argosy Cruise
06:15 PM – 07:00 PM Product Theater Sponsored by Janssen
Topic: Janssen Oncology Leading the Way with 5 Immunotherapies in Multiple Myeloma
Speaker: James R. Berenson, MD
07:00 PM – 07:30 PM Dinner
07:30 PM – 08:15 PM Career Connections Session
**This is a non-CME activity**
Sponsored by Genentech
DAY 2 - APRIL 27, 2024
07:00 AM – 08:00 AM Registration, Breakfast, & Exhibits
08:00 AM – 09:30 AM Session 6: Community Engagement
Session Chair: Martha Pritchett Mims, MD, PhD
08:00 AM – 08:20 AM A Latino Lens: Listening to the Community to Fuel Outreach and Education - Amelie G. Ramirez, DrPH, MPH
08:20 AM – 08:35 AM OPTIMISE Oncology - Primary Care Partnership to Improve Comprehensive Survivorship Care - Hoda J. Badr, PhD
08:35 AM – 08:50 AM Shifting the lens: Engagement of Tribal communities in cancer clinical trials - Andrew Sussman, PhD, MCRP
08:50 AM – 09:05 AM Reaching Spanish Preferring Populations with Cancer Education and Screening - Susan T. Vadaparampil, PhD, MPH
09:05 AM – 09:30 AM Panel Discussion
09:30 AM – 10:00 AM Break & Exhibits
10:00 AM – 11:00 AM Session 7: Drug Shortage
Session Chairs: Hannah M. Linden, MD, FACP and Shailender Bhatia, MD
10:00 AM – 10:15 AM Impossible Choices in Challenging Circumstances: Dealing with Decades of Drug Shortages - Karen Hagerty, MD
10:15 AM – 10:30 AM Drug shortages: Upstream Factors and Policy Solutions - Mariana Peixoto Socal, MD, PhD
10:30 AM – 11:00 AM Panel Discussion - W. Thomas Purcell, MD, MBA
11:00 AM – 12:00 PM Session 8: Oncology Leaders' Approach to Cancer Health Disparities
Moderator: Amelie G. Ramirez, DrPH, MPH
Panelists: Margaret Foti, PhD, MD (hc); Jorge E. Cortes, MD; Joseph R. Mikhael, MD, MEd, FRCPC, FACP
12:00 PM – 01:00 PM Lunch & Exhibits
01:00 PM – 02:30 PM Session 9: Clinical Trials & Research Diversity
Session Chair: Jorge E. Cortes, MD
01:00 PM – 01:20 PM Access to Clinical Trials: An Equity and Social Justice Opportunity - Nadine J. Barrett, PhD, MA, MS
01:20 PM – 01:30 PM Can We Increase Accrual of Minorities in Rural Areas of the Country? A 12 Year Journey - Sharad Ghamande, MD, FACOG
01:30 PM – 01:40 PM Using Culturally-Tailored Edutainment Videos to Facilitate Recruitment and Decision-Making about Cancer Clinical Trials - Vida Henderson, PhD, PharmD, MPH, MFA
01:40 PM – 01:50 PM A Simple, Intuitive-Approach for Assessing Clinical Trial Data to Evaluate Outcomes for Under-Represented Patient Populations - Roger M. Stein, PhD
01:50 PM – 02:00 PM "How can you begin to think about a clinical trial when you can't get food on the table?" A Community Health Worker-led Health Related Social Needs Intervention and the Impact on Clinical Trial Education and Accrual - Manali I. Patel, MD, MPH, MS, FASCO
02:00 PM – 02:30 PM Panel Discussion - Jerald Radich, MD; Jason A. Mendoza, MD, MPH
02:30 PM – 02:45 PM Break & Exhibits
02:45 PM – 04:15 PM Session 10: Global Oncology
Session Chair: Dan A. Milner, Jr., MD, MSc(EPi), MBA, FASCP
02:45 PM – 03:05 PM Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA
03:05 PM – 03:15 PM New Technologies to Enhance Innate Immunity for the Prevention and Treatment of Cancer in Low Resource Settings - Corey Casper, MD, MPH
03:15 PM – 03:25 PM Developing Global Cancer Mentorship: A Pilot Experience with Rwanda - Regine Nshimiyimana Maniraho, DNP, BPharm, FNP, AGACNP, AOCNP
03:25 PM – 03:35 PM Access to Medications: Cases Studies in Solutions - Dan A. Milner, Jr., MD, MSc(EPi), MBA, FASCP
03:35 PM – 03:45 PM Case Study: Behind the Scenes of 'Streamlined' Care - Joseph Rosales, MD
03:45 PM – 04:15 PM Panel Discussion - Yogendra P. Singh, MBBS, MD
06:00 PM – 08:30 PM Binaytara Foundation Gala Dinner
DAY 3 - APRIL 28, 2024
07:00 AM – 08:00 AM Registration, Breakfast, & Exhibits
07:30 AM – 09:00 AM Session 11: Poster Abstract Session
**This is a non-CME activity**
09:00 AM – 10:30 AM Session 12: Debate: Is Universal Healthcare A Solution to U.S. Healthcare Disparities?
Moderators: Manisha Bhattacharya, MD, MBA and Aaron Goodman, MD
Panelists: Karen E. Knudsen, MBA, PhD (CEO of the American Cancer Society); Sen. Manka Dhingra (Deputy Majority Leader of the Washington State Senate); Barbara L. McAneny, MD (Past-President of the American Medical Association); Willie Underwood, III, MD, MSc, MPH (Chair of the American Medical Association Board of Trustees); Rep. Adam Smith (Representative for Washington's 9th Congressional District); Isaac Opole, MD, MBChB, PhD, FACP (President of the American College of Physicians)
10:30 AM – 10:45 AM Break & Exhibits
10:45 AM – 11:45 AM Session 13: Oral Abstract Session
Session Chairs: Martha Pritchett Mims, MD, PhD and Darya Kizub, MD
10:45 AM – 10:57 AM Racial Disparities in GU Cancer Metastasis: A Comprehensive Analysis from 2010-2018 - Abdul Rahman Al Armashi, MD
10:57 AM – 11:09 AM Remote Contouring Education in Latin America: Longitudinal Effects of Asynchronous Resources with or without Synchronous Virtual Lectures - Michael Dykstra, MD
11:09 AM – 11:21 AM The SC AMEN Program for Black Men: Providing Education and Navigation to Prostate Cancer Screening with Informed Decision Making - Marvella E. Ford, PhD
11:21 AM – 11:33 AM Mobile Screening Mammogram Program Serves Vulnerable Population - John L. Bell, MD, FACS, FSSO
11:33 AM – 11:45 AM An Updated Case Study: Successful Implementation of an Electronic Medical Record System at BTFCC in Nepal - Anish Shah, MD
11:45 AM – 12:00 PM Abstract Awards
**This is a non-CME activity**
12:00 PM Adjourn
IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:
All conflict of interest has been identified and mitigated for individuals in control of contents.
PLANNING COMMITTEE DISCLOSURE STATEMENT:
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
Binay Shah, MD, MHA
David Aboulafia, MD
Hannah Linden, MD FACP
Ana Maria Lopez, MD, MPH
David Aboulafia, MD
Shailender Bhatia, MD
Jorge Cortes, MD
Manish Kohli
Ana Maria Lopez, MD, MPH
Danny Milner, Jr, MD, MSc, MBA
Martha Mims
Kamran Mirza, MD PhD
Mark Pegram, MD
Gita Suneja, MD, MSHP
Siddhartha Yadav, Siddhartha Yadav, MD, FACP
Michele Andrasik, PhD, EdM, MA, MS
Nadine Barrett, PhD, MA., MS
Elle Brooks
Alan Brownell
Siddhartha Devarakonda, MBBS, MD
Manka Dhingra
Joseph Finkelstein, MD, PhD, FAMIA, FACMI
Carrie Fisher, DO
Margaret Foti
Nicholas Giustini, MD
Stephen Grubbs
Karen Hagerty
Carrie Horwitch, MD, MPH
Irum Khan, MD, MS
Karen Knudsen, MBA, PhD
Roger M Stein
Derrick Mapp
Jason Mendoza, MD, MPH
Joseph Mikhael, MD, MEd, FRCPC
Regine Nshimiyimana Maniraho, DNP, BPharm, FNP, AGACNP, AOCNP
Isaac Opole
Tom purcell, MD, MBA
Jerald Radich
Amelie Ramirez, DrPH
Adam Smith
Mariana Socal, MD, PhD, MS, MPP
Ishwaria Subbiah, MD, MS
Willie Underwood, III
Susan Vadaparampil
Ulka Vaishampayan, MD
Nakita Venus
Hoda Badr, PhD
Michael Barr, MD, MBA, MACP, FRCP
Corey Casper, MD, MPH
Shelley Fuld Nasso, MPP
Sharad Ghamande
Vida Henderson
Barbara McAneny
Manali Patel, MD, MPH, MS, FASCO
Joseph Rosales, MD
Yogendra Singh
Aref Smiley
Andrew Sussman, PhD, MCRP
Aaron Goodman, MD
Manisha Bhattacharya
Ursa Brown-Glaberman, Associate Professor
Ronan Hsieh, MD, MS
Darya Kizub, MD
Umang Swami, MD, MS
Srinivas Tantravahi, MBBS; MRCP
Dipesh Uprety, MD, FACP
Gregory Vidal, MD,PhD
Fengting Yan, MD
Acknowledgment of Commercial Support
This activity is supported with an independent medical education grant from:
- AbbVie Inc.
Available Credit
- 14.25 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 14.25 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 14.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 14.25 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 14.25 Contact Hours.
We would like to thank the following exhibitors and supporters:
Company | Exhibit Type | Exhibitor Name |
Amgen | General Exhibit | Laurie Thibert |
Astrazeneca | Premium Exhibit | Kay Walz |
Biocartis | General Exhibit | Cedric Hahn |
Biotheranostics | General Exhibit | Ramzi Karlous |
Boehringer Ingelheim | General Exhibit | David Waldron |
Caris Life Sciences | General Exhibit | Heidi Sanderson |
Daiichi Sankyo, Inc. | Premium Exhibit | Robert Gardipee |
Eisai | General Exhibit | Christie Thompson |
Exelixis | General Exhibit | Carey Miailovich |
Foundation Medicine | General Exhibit | Sheri Storey |
Gilead | General Exhibit | Scott Theiste |
GSK Oncology | General Exhibit | Fatima Surani |
Immunocore | General Exhibit | Patrick Short |
Incyte Corporation | General Exhibit | Michael Roh |
Janssen Exhibit Table | General Exhibit | Kara Rosso |
Kite Pharmaceuticals | General Exhibit | Brad Arnsmeier |
Menarini Stemline | General Exhibit | Dwayne Tyner |
Merck | General Exhibit | Heidi Wilkes |
Novartis | General Exhibit | Eric Morales |
Novartis Oncology | General Exhibit | Christine Emert |
Pfizer Oncology | Premium Exhibit | Donna Corsell |
Pharmaessentia | General Exhibit | Alicia Moss |
Regeneron | General Exhibit | Manuel Almario |
Seagen | General Exhibit | Kelsie Konigsberger |
Servier Pharmaceuticals | General Exhibit | Susan Tokish |
Price
Register for our Annual Gala! Click the image below:
POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE:
The registration fee for employees of companies not supporting this meeting is $1500. If your company is a supporter of this meeting, please review the prospectus for pricing.
All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place.
The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference. The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees.
If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot, or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including any pleasantries, introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.
Violating this policy will result in a fine equivalent to a general display fee for that conference.
If your company has purchased an exhibit or sponsorship, please register at the link below to receive the discounted registration fees:
Link to register as an additional rep of a sponsoring company: https://education.
NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
- If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
CANCELLATION POLICY
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
- No refunds will be issued if registration is canceled after that date.
No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.